Statizoid

Health in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)

491 indicators covering health for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD).

IndicatorLatest Year10-yr change Rank
Maternal mortality ratio 132 2023 down 24.6% 18th
Number of maternal deaths, per capita 0 units per person 2023 down 35.5% 17th
Number of maternal deaths, per unit of GDP 0 units per US$ of GDP 2023 down 29.1% 14th
Number of maternal deaths, per square kilometre 0.0023 units per square kilometre 2023 down 23.3% 19th
Number of maternal deaths, annual growth rate -4.17 % change on previous year 2023 down 29.2% 20th
Probability of dying among adolescents ages 10-19 years 6.42 per 1,000 2024 down 21.9% 19th
Probability of dying among children ages 5-9 years, female 2.27 per 1,000 2024 down 32.3% 19th
Probability of dying among children ages 5-9 years, male 2.95 per 1,000 2024 down 27.1% 19th
Probability of dying among adolescents ages 10-14 years, female 1.98 per 1,000 2024 down 26.1% 21st
Probability of dying among adolescents ages 10-14 years, male 2.86 per 1,000 2024 down 20.5% 18th
Probability of dying among adolescents ages 10-19 years, female 4.79 per 1,000 2024 down 21.5% 23rd
Probability of dying among adolescents ages 10-19 years, male 7.95 per 1,000 2024 down 22.3% 22nd
Probability of dying among adolescents ages 15-19 years, female 2.82 per 1,000 2024 down 16.9% 23rd
Probability of dying among adolescents ages 15-19 years, male 5.11 per 1,000 2024 down 22.3% 24th
Probability of dying among youth ages 20-24 years, female 3.12 per 1,000 2024 down 8.8% 28th
Probability of dying among youth ages 20-24 years, male 7.61 per 1,000 2024 down 19.2% 25th
Women's share of population ages 15+ living with HIV 33.2% 2024 up 0.4% 16th
Prevalence of HIV, female 0.1% 2024 down 0.2% 19th
Prevalence of HIV, male 0.1% 2024 down 0.2% 20th
Prevalence of overweight, female 64.5% 2022 up 15.2% 10th
Prevalence of overweight, male 55.1% 2022 up 21.0% 18th
Prevalence of overweight 59.8% 2022 up 17.9% 13th
Immunization, HepB3 83.6% 2024 up 6.5% 28th
Newborns protected against tetanus 84.1% 2024 up 5.0% 13th
Population ages 00-04, female 10.9% 2025 down 15.6% 15th
Population ages 00-04, male 11.1% 2025 down 15.0% 15th
Population ages 05-09, female 10.8% 2025 down 6.6% 16th
Population ages 05-09, male 11.0% 2025 down 6.3% 15th
Population ages 15-19, female 9.6% 2025 up 0.2% 15th
Population ages 15-19, male 9.8% 2025 up 0.3% 15th
Population ages 10-14, female 10.6% 2025 up 3.6% 15th
Population ages 10-14, male 10.9% 2025 up 3.7% 15th
Population ages 20-24, female 8.4% 2025 down 7.0% 19th
Population ages 20-24, male 8.6% 2025 down 7.4% 18th
Population ages 25-29, female 7.7% 2025 down 10.6% 23rd
Population ages 25-29, male 7.8% 2025 down 10.0% 24th
Population ages 30-34, female 7.2% 2025 down 5.4% 18th
Population ages 30-34, male 7.4% 2025 down 4.1% 24th
Population ages 35-39, female 6.9% 2025 up 8.6% 26th
Population ages 35-39, male 6.9% 2025 up 9.1% 29th
Population ages 40-44, female 6.2% 2025 up 15.6% 33rd
Population ages 40-44, male 6.2% 2025 up 15.4% 33rd
Population ages 45-49, female 5.1% 2025 up 11.4% 33rd
Population ages 45-49, male 5.1% 2025 up 12.3% 33rd
Population ages 50-54, female 4.3% 2025 up 9.3% 33rd
Population ages 50-54, male 4.2% 2025 up 11.1% 34th
Population ages 55-59, female 3.6% 2025 up 14.1% 32nd
Population ages 55-59, male 3.5% 2025 up 14.8% 34th
Population ages 60-64, female 3.0% 2025 up 20.0% 32nd
Population ages 60-64, male 2.8% 2025 up 19.4% 32nd
Population ages 65-69, female 2.3% 2025 up 26.5% 32nd
Population ages 65-69, male 2.1% 2025 up 25.4% 32nd
Population ages 70-74, female 1.6% 2025 up 28.9% 31st
Population ages 70-74, male 1.4% 2025 up 27.4% 31st
Population ages 75-79, female 1.0% 2025 up 19.3% 31st
Population ages 75-79, male 0.8% 2025 up 17.3% 31st
Population ages 80 and above, female 0.8% 2025 up 16.5% 33rd
Population ages 80 and above, male 0.6% 2025 up 10.9% 31st
Population ages 00-04, female 40.25 million 2025 up 0.6% 24th
Population ages 00-04, male 42.16 million 2025 up 0.3% 24th